# Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris.

> **NCT03752242** · PHASE2 · TERMINATED · sponsor: **BioMimetix JV, LLC** · enrollment: 2 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** BMX-010 0.3%

## Key facts

- **NCT ID:** NCT03752242
- **Lead sponsor:** BioMimetix JV, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-01-03
- **Primary completion:** 2020-08-31
- **Final completion:** 2020-08-31
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Enrollment stopped for chemistry work on investigational product.
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03752242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03752242, "Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03752242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*